Ads
related to: disposable slide sheets for patients with cancer risk services
Search results
Results From The WOW.Com Content Network
Personalized cancer treatment is a tuned method based on the patient's diagnosis and background. Microfluidic technology offers sensitive detection with higher throughput, as well as reduced time and costs. For personalized cancer treatment, tumor composition and drug sensitivities are very important. [144]
This is why we have the ‘single-use’ designation, and it is validly used to ensure patient safety and patient care efficacy.” Many companies add the single use label, to increase sales. “However, a small amount of single-use devices can be re-used, after going through stringent and controlled procedures.
Many or most of these items are disposable to avoid carrying infectious materials from one patient to another patient and to avoid difficult or costly disinfection. In the US, OSHA requires the immediate removal and disinfection or disposal of a worker's PPE prior to leaving the work area where exposure to infectious material took place. [20]
A set of standard 75 by 25 mm microscope slides. The white area can be written on to label the slide. A microscope slide (top) and a cover slip (bottom) A microscope slide is a thin flat piece of glass, typically 75 by 26 mm (3 by 1 inches) and about 1 mm thick, used to hold objects for examination under a microscope.
AOL latest headlines, entertainment, sports, articles for business, health and world news.
The Common Terminology Criteria for Adverse Events (CTCAE), [1] formerly called the Common Toxicity Criteria (CTC or NCI-CTC), are a set of criteria for the standardized classification of adverse events of drugs and treatment used in cancer therapy. The CTCAE system is a product of the US National Cancer Institute (NCI).
The Prescribing Information follows one of two formats: "physician labeling rule" format or "old" (non-PLR) format. For "old" format labeling a "product title" may be listed first and may include the proprietary name (if any), the nonproprietary name, dosage form(s), and other information about the product.
Follow-up of cancer patients after successful treatment; Palliative care of patients with terminal malignancies; Ethical questions surrounding cancer care; Screening efforts: of populations, or; of the relatives of patients (in types of cancer that are thought to have a hereditary basis, such as breast cancer)